您的位置: 首页 > 农业专利 > 详情页

ANALOGUES DE GLP-2 ET PEPTIBODIES DESTINES A ETRE ADMINISTRES AVANT, PENDANT OU APRES UNE INTERVENTION CHIRURGICALE
专利权人:
SHIRE-NPS PHARMACEUTICALS; INC.
发明人:
PAN, CLARK,NORTON, ANGELA,STRACK-LOGUE, BETTINA,OLIVIER, CLEMENT
申请号:
CA3079523
公开号:
CA3079523A1
申请日:
2018.11.05
申请国别(地区):
CA
年份:
2019
代理人:
摘要:
GLP-2 analogs, such as teduglutide, and fusion proteins of GLP-2 with immunoglobulin are administered before, during or after surgery, particularly resection of the small intestine. When short bowel syndrome develops after surgical resection of the small intestine, parenteral nutrition is usually necessary to compensate for reduced absorption of water and nutrients across the small intestine. GLP-2 analogs and GLP-2 fusion proteins promote growth of small intestine, improve nutrient absorption and can reduce the need for parenteral nutrition after surgery.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充